A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

PHASE1CompletedINTERVENTIONAL

Enrollment

137

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

August 19, 2025

Study Completion Date

August 19, 2025

Conditions

Healthy Participants

Interventions

DRUG

INCB160058

Oral; Immediate release solid tablet

DRUG

Placebo

Oral; Tablet

DRUG

Esomeprazole

Oral; Delayed-release capsule or tablet

DRUG

Famotidine

Oral; Tablet

Trial Locations (1)

Nucleus Network Pty Ltd, Melbourne